The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 12 - 2024 |
doi: 10.3389/fpubh.2024.1521798
This article is part of the Research Topic Drivers of Antimicrobial Resistance during and After COVID-19 Pandemic in Low-Middle-Income Countries View all 9 articles
Editorial: Drivers of Antimicrobial Resistance During and After COVID-19 Pandemic in Low-Middle Income Countries
Provisionally accepted- 1 School of Pharmaceutical Sciences, University of Science Malaysia, Pulau Pinang, Penang, Malaysia
- 2 Jouf University, Sakakah, Al Jawf, Saudi Arabia
- 3 University of Veterinary and Animal Sciences, Lahore, Punjab, Pakistan
- 4 Department of Pharmacy Practice, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore, Pakistan
Antimicrobial resistance (AMR) is among the top ten global health threats compromising healthcare delivery systems due to associated morbidity, mortality and economic loss [1]. It is estimated that 1.14 million deaths (95% uncertainty interval: 1.00-1.28 million) were attributed to bacterial AMR in 2021 [2]. Irrational antimicrobial agents' use is one of the key contributors to the development of AMR and the highest mortality and economic burden associated with AMR has been seen in low-and middle-income countries (LMICs) [2,3].COVID-19 pandemic is arguably the most devastating health crisis faced by humanity since the influenza pandemic in 1918 [4,5]. The disease has claimed the life of millions of people since its emergence in late 2019 [6]. At the start of pandemic, several therapeutics modalities were used to manage COVID-19 patients (e.g. symptomatic treatment, drug repurposing, antivirals, convalescent plasma etc.) as there was no approved treatment or vaccine for the disease existed that time. In addition to the above-mentioned treatments, inappropriate antibiotics use was rampant amid COVID-19 pandemic, adding to the already prevalent issue of AMR, a pandemic within a pandemic. Consequently, our research topic delves into the main drivers of AMR during and after COVID-19 pandemic. This articles' collection can help highlight various factors contributing to AMR, thus helping heath authorities to devise further strategies to counter the threat of AMR. We are grateful to all the contributors to our research topic. This collection includes a total of eight articles. ( 1 Overall, the article featured in this research topic underscores the crucial importance of judicious use of antimicrobial agents and overcoming the barriers to implementing AMS to combat AMR.We are deeply grateful to all the authors for their valuable contributions to this critical topic.Additionally, we extend our thanks to the reviewers for dedicating their time to evaluate and enhance the research articles. We hope the content published in our special issue significantly contributes to global efforts in tackling antimicrobial resistance.
Keywords: Antibiotics use, Antimicrobial resistance (AMR), Antimicrobial stewardship (AMS), Antimicrobial use, Low- and lower-middle-income countries
Received: 02 Nov 2024; Accepted: 25 Nov 2024.
Copyright: © 2024 Mustafa, Mallhi, Khan, Hayat and Salman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Muhammad Salman, Department of Pharmacy Practice, Institute of Pharmacy, Faculty of Pharmaceutical and Allied Health Sciences, Lahore College for Women University, Lahore, Pakistan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.